For Any Query Call @ +91 9368710882 Open 100% Free Paperless Demat Account @ http://bit.ly/2OuyXNJ More Info Visit @ http://bit.ly/33yTc0V Windlas Biotech Ltd 2001 me incorporate hui thi or ye CDMO segment me India ki one of the leading companies me se ek hai. Ye bahut sari badi companies ko apne products export karti hai jaise ki Pfizer, sanofi, cadilla etc IPO Date 04 august to 06 august Face value rs 5 per equity share IPO price 448 to 460 per equity share Market lot 30 shares Issue size 401.54 cr Fresh Issue 154 cr OFS 236.54 cr Share market is subject to market Risk. Past performance isn't a guarantee of future performance. The possibility of loss in trading and investment in the share market including equity, derivatives, commodity, and currency are often substantial. These are leveraged products that carry a substantial risk of loss up to your invested capital and will not be suitable for everyone. You need to therefore carefully consider whether such trading is suitable for you in light of your financial condition. Please confirm that you simply understand fully the risks involved and do invest money according to your risk-bearing capacity. Raghunandan Money and an individual associated with this channel accept no liability for any quite content uploaded on this channel or responsibility for any direct, indirect, implied, punitive, special, incidental or other consequential damages, arising, directly or indirectly on account of any action taken supporting the knowledge provided on this channel. We request people to not take our content too seriously & we sincerely apologize for any such hurt our video may need caused. Visit @ https://rmoneyindia.com/ Facebook @ https://www.facebook.com/pages/Raghun... Twitter @ https://twitter.com/Rmoneyindia Linkedin @ https://www.linkedin.com/company/ragh…
IT'S TIME TO HAVE SOME FUN!
Your family deserves this time more than we do.
Share happiness with your family today & come back soon. We will be right here.
Investment to ek bahana hai,
humein to khushiyon ko badhana hai.